Insider Transactions in Q1 2023 at Agios Pharmaceuticals, Inc. (AGIO)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 27
2023
|
David P Schenkein Director |
SELL
Open market or private sale
|
Direct |
20,000
-14.51%
|
$440,000
$22.15 P/Share
|
|
Mar 27
2023
|
David P Schenkein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+12.67%
|
$180,000
$9.05 P/Share
|
|
Mar 13
2023
|
David P Schenkein Director |
SELL
Open market or private sale
|
Direct |
20,000
-7.35%
|
$440,000
$22.59 P/Share
|
|
Mar 13
2023
|
David P Schenkein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+12.67%
|
$180,000
$9.05 P/Share
|
|
Mar 03
2023
|
Theodore James Washburn Jr. Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
504
-15.53%
|
$12,096
$24.29 P/Share
|
|
Mar 03
2023
|
Sarah Gheuens Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,134
-5.34%
|
$28,350
$25.02 P/Share
|
|
Mar 03
2023
|
James William Burns Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,129
-4.12%
|
$28,225
$25.02 P/Share
|
|
Mar 01
2023
|
Sarah Gheuens Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,833
+15.28%
|
-
|
|
Mar 01
2023
|
James William Burns Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,833
+12.28%
|
-
|
|
Mar 01
2023
|
Theodore James Washburn Jr. Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
273
-7.76%
|
$6,825
$25.31 P/Share
|
|
Mar 01
2023
|
Theodore James Washburn Jr. Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
777
+18.09%
|
-
|
|
Feb 27
2023
|
David P Schenkein Director |
SELL
Open market or private sale
|
Direct |
20,000
-14.51%
|
$500,000
$25.37 P/Share
|
|
Feb 27
2023
|
David P Schenkein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+12.67%
|
$180,000
$9.05 P/Share
|
|
Feb 16
2023
|
Theodore James Washburn Jr. Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
233
-8.03%
|
$6,291
$27.21 P/Share
|
|
Feb 16
2023
|
Jacqualyn A Fouse Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,648
-4.23%
|
$102,144
$28.91 P/Share
|
|
Feb 16
2023
|
James William Burns Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
609
-2.52%
|
$17,052
$28.91 P/Share
|
|
Feb 14
2023
|
Jacqualyn A Fouse Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,333
+11.62%
|
-
|
|
Feb 14
2023
|
James William Burns Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,738
+6.71%
|
-
|
|
Feb 14
2023
|
Theodore James Washburn Jr. Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
504
-14.8%
|
$14,112
$28.59 P/Share
|
|
Feb 14
2023
|
Theodore James Washburn Jr. Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
400
-5.76%
|
$11,200
$28.68 P/Share
|
|
Feb 14
2023
|
Theodore James Washburn Jr. Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
360
+9.25%
|
-
|
|
Feb 14
2023
|
Sarah Gheuens Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
758
-4.27%
|
$21,224
$28.44 P/Share
|
|
Feb 14
2023
|
James William Burns Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
643
-2.79%
|
$18,004
$28.44 P/Share
|
|
Feb 13
2023
|
David P Schenkein Director |
SELL
Open market or private sale
|
Direct |
20,000
-14.51%
|
$560,000
$28.62 P/Share
|
|
Feb 13
2023
|
David P Schenkein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+12.67%
|
$180,000
$9.05 P/Share
|
|
Feb 10
2023
|
Sarah Gheuens Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,162
+10.85%
|
-
|
|
Feb 10
2023
|
James William Burns Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,834
+7.37%
|
-
|
|
Feb 10
2023
|
Theodore James Washburn Jr. Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
777
+18.4%
|
-
|
|
Jan 30
2023
|
David P Schenkein Director |
SELL
Open market or private sale
|
Direct |
20,000
-7.42%
|
$580,000
$29.55 P/Share
|
|
Jan 30
2023
|
David P Schenkein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+12.67%
|
$180,000
$9.05 P/Share
|
|
Jan 17
2023
|
David P Schenkein Director |
SELL
Open market or private sale
|
Direct |
20,000
-7.31%
|
$580,000
$29.16 P/Share
|
|
Jan 17
2023
|
David P Schenkein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+12.67%
|
$180,000
$9.05 P/Share
|
|
Jan 13
2023
|
Kaye I Foster Cheek Director |
SELL
Bona fide gift
|
Direct |
2,200
-25.15%
|
-
|